NCT06638307 2026-03-11
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Stemline Therapeutics, Inc.
Phase 1 Recruiting
Stemline Therapeutics, Inc.
DIGMBIO
Jiangsu HengRui Medicine Co., Ltd.
Shenzhen Celconta Life Science Co., Ltd.